Antimalarial combination (DHA-piperaquine)
Piperaquine phosphate with artenimol
Brand names: Eurartesim
Adult dose
Dose: Weight-based once daily for 3 days; e.g. 75–100kg: 4 tabs (320mg/40mg) OD x3
Route: PO
Frequency: OD x 3 days
Clinical pearls
- Uncomplicated P. falciparum malaria
- Take on empty stomach — high-fat meal markedly increases absorption and QT effect
Contraindications
- QT prolongation
- Severe hepatic impairment
- Concurrent QT-prolonging drugs
- First-trimester pregnancy
Side effects
- QT prolongation
- Headache
- Anaemia
- Eosinophilia
- Bradycardia
- Hepatotoxicity
Interactions
- QT-prolonging drugs
- Strong CYP3A4 modulators
Monitoring
- ECG
- FBC
- LFTs
Reference: BNF; UKHSA malaria guidance; SmPC; https://bnf.nice.org.uk/drugs/piperaquine-phosphate-with-artenimol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023